242 related articles for article (PubMed ID: 24029230)
1. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.
Nagamachi A; Matsui H; Asou H; Ozaki Y; Aki D; Kanai A; Takubo K; Suda T; Nakamura T; Wolff L; Honda H; Inaba T
Cancer Cell; 2013 Sep; 24(3):305-17. PubMed ID: 24029230
[TBL] [Abstract][Full Text] [Related]
2. Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome.
Asou H; Matsui H; Ozaki Y; Nagamachi A; Nakamura M; Aki D; Inaba T
Biochem Biophys Res Commun; 2009 May; 383(2):245-51. PubMed ID: 19358830
[TBL] [Abstract][Full Text] [Related]
3. Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome.
Cammenga J
Exp Hematol; 2024 Jun; 134():104217. PubMed ID: 38649131
[TBL] [Abstract][Full Text] [Related]
4. The enigma of monosomy 7.
Inaba T; Honda H; Matsui H
Blood; 2018 Jun; 131(26):2891-2898. PubMed ID: 29615405
[TBL] [Abstract][Full Text] [Related]
5. [Association between SAMD9/SAMD9L and hematological malignancies].
Narumi S; Hasegawa T
Rinsho Ketsueki; 2018; 59(11):2475-2480. PubMed ID: 30531146
[TBL] [Abstract][Full Text] [Related]
6. [Monosomy 7: recent progress].
Inaba T; Nagamachi A
Rinsho Ketsueki; 2019; 60(9):1020-1026. PubMed ID: 31597823
[TBL] [Abstract][Full Text] [Related]
7. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.
Wong JC; Bryant V; Lamprecht T; Ma J; Walsh M; Schwartz J; Del Pilar Alzamora M; Mullighan CG; Loh ML; Ribeiro R; Downing JR; Carroll WL; Davis J; Gold S; Rogers PC; Israels S; Yanofsky R; Shannon K; Klco JM
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046003
[TBL] [Abstract][Full Text] [Related]
8. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
Davidsson J; Puschmann A; Tedgård U; Bryder D; Nilsson L; Cammenga J
Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
[TBL] [Abstract][Full Text] [Related]
9. Constitutional
Pastor VB; Sahoo SS; Boklan J; Schwabe GC; Saribeyoglu E; Strahm B; Lebrecht D; Voss M; Bryceson YT; Erlacher M; Ehninger G; Niewisch M; Schlegelberger B; Baumann I; Achermann JC; Shimamura A; Hochrein J; Tedgård U; Nilsson L; Hasle H; Boerries M; Busch H; Niemeyer CM; Wlodarski MW
Haematologica; 2018 Mar; 103(3):427-437. PubMed ID: 29217778
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations.
Ahmed IA; Farooqi MS; Vander Lugt MT; Boklan J; Rose M; Friehling ED; Triplett B; Lieuw K; Saldana BD; Smith CM; Schwartz JR; Goyal RK
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2186-2196. PubMed ID: 31306780
[TBL] [Abstract][Full Text] [Related]
11. [Significance of chromosome 7 abnormalities in myeloid malignancies].
Shi WH; Li X; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1739-43. PubMed ID: 25543507
[TBL] [Abstract][Full Text] [Related]
12. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.
McNerney ME; Brown CD; Wang X; Bartom ET; Karmakar S; Bandlamudi C; Yu S; Ko J; Sandall BP; Stricker T; Anastasi J; Grossman RL; Cunningham JM; Le Beau MM; White KP
Blood; 2013 Feb; 121(6):975-83. PubMed ID: 23212519
[TBL] [Abstract][Full Text] [Related]
13. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
Thomas ME; Abdelhamed S; Hiltenbrand R; Schwartz JR; Sakurada SM; Walsh M; Song G; Ma J; Pruett-Miller SM; Klco JM
Leukemia; 2021 Nov; 35(11):3232-3244. PubMed ID: 33731850
[TBL] [Abstract][Full Text] [Related]
14. Gain-of-function
Tesi B; Davidsson J; Voss M; Rahikkala E; Holmes TD; Chiang SCC; Komulainen-Ebrahim J; Gorcenco S; Rundberg Nilsson A; Ripperger T; Kokkonen H; Bryder D; Fioretos T; Henter JI; Möttönen M; Niinimäki R; Nilsson L; Pronk CJ; Puschmann A; Qian H; Uusimaa J; Moilanen J; Tedgård U; Cammenga J; Bryceson YT
Blood; 2017 Apr; 129(16):2266-2279. PubMed ID: 28202457
[TBL] [Abstract][Full Text] [Related]
15. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
16. A long lasting puzzle for -7/7q- syndrome.
Honda H; Inaba T
Oncotarget; 2014 Jan; 5(1):7-8. PubMed ID: 24473927
[No Abstract] [Full Text] [Related]
17. Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis.
Li Q; Guo H; Matsui H; Honda H; Inaba T; Sundberg JP; Sprecher E; Uitto J
Exp Dermatol; 2012 Jul; 21(7):554-6. PubMed ID: 22716256
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans.
Buonocore F; Kühnen P; Suntharalingham JP; Del Valle I; Digweed M; Stachelscheid H; Khajavi N; Didi M; Brady AF; Blankenstein O; Procter AM; Dimitri P; Wales JKH; Ghirri P; Knöbl D; Strahm B; Erlacher M; Wlodarski MW; Chen W; Kokai GK; Anderson G; Morrogh D; Moulding DA; McKee SA; Niemeyer CM; Grüters A; Achermann JC
J Clin Invest; 2017 May; 127(5):1700-1713. PubMed ID: 28346228
[TBL] [Abstract][Full Text] [Related]
19. Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.
Wong JC; Zhang Y; Lieuw KH; Tran MT; Forgo E; Weinfurtner K; Alzamora P; Kogan SC; Akagi K; Wolff L; Le Beau MM; Killeen N; Shannon K
Blood; 2010 Jun; 115(22):4524-32. PubMed ID: 20233966
[TBL] [Abstract][Full Text] [Related]
20. Multiorgan failure with abnormal receptor metabolism in mice mimicking Samd9/9L syndromes.
Nagamachi A; Kanai A; Nakamura M; Okuda H; Yokoyama A; Shinriki S; Matsui H; Inaba T
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33373325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
